EcoDrugPlus

Estrogen Receptor Beta-Like

Ensembl ID : ENSSLUG00000000891
Gene Symbol: LOC116066349
3 Cross references
198 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSSLUG00000010784
Gene Symbol: ESRRG
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSLUG00000003545
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSLUG00000009410
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSSLUG00000005158
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSLUG00000024901
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSSLUG00000009001
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSSLUG00000006965
Gene Symbol: FGFR1A
1 Cross references
205 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSSLUG00000017997
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSSLUG00000020851
Gene Symbol: FGFR3
1 Cross references
192 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSSLUG00000001549
Gene Symbol: FLT1
1 Cross references
198 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSSLUG00000014816
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).